Omeros - 16 Year Stock Price History | OMER

Historical daily share price chart and data for Omeros since 2009 adjusted for splits and dividends. The latest closing stock price for Omeros as of July 07, 2025 is 3.08.
  • The all-time high Omeros stock closing price was 26.69 on September 04, 2018.
  • The Omeros 52-week high stock price is 13.60, which is 341.6% above the current share price.
  • The Omeros 52-week low stock price is 2.95, which is 4.2% below the current share price.
  • The average Omeros stock price for the last 52 weeks is 6.21.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Omeros Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 6.7522 9.8400 11.2100 2.9700 3.0800 -68.83%
2024 4.6401 3.2900 12.1500 2.8800 9.8800 202.14%
2023 3.8862 2.4800 7.5700 1.0800 3.2700 44.69%
2022 4.2523 6.9900 7.4600 1.7500 2.2600 -64.85%
2021 14.5458 14.5200 23.5300 5.6700 6.4300 -54.99%
2020 13.3243 13.6150 21.3200 9.0300 14.2850 1.38%
2019 16.0534 11.8500 20.5600 11.6500 14.0900 26.48%
2018 16.9450 20.1550 26.6900 9.0000 11.1400 -42.67%
2017 17.1065 10.1000 26.5800 8.9500 19.4300 95.87%
2016 11.5152 14.7900 16.3700 7.3400 9.9200 -36.94%
2015 18.3820 25.0100 26.3500 10.9000 15.7300 -36.52%
2014 14.3080 12.0600 24.7800 9.9400 24.7800 119.49%
2013 6.4532 5.3900 13.2300 3.7600 11.2900 117.53%
2012 8.6929 4.0000 13.2500 3.9900 5.1900 31.39%
2011 4.8167 8.5000 8.5000 3.1700 3.9500 -52.06%
2010 6.8037 7.2900 8.7700 5.2400 8.2400 17.38%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.188B $0.000B
Omeros Corporation is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. Omeros' most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. Omeros has four ongoing PharmacoSurgery(TM) clinical development programs, and its lead product candidate, OMS103HP, is being evaluated in Phase 3 clinical trials for use during arthroscopic surgery to improve postoperative joint function and reduce postoperative pain. Omeros is also building a diverse pipeline of preclinical programs targeting inflammation and central nervous system disorders.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.904B 28.13
Boston Scientific (BSX) United States $154.336B 38.64
Stryker (SYK) United States $150.874B 31.55
EssilorLuxottica (ESLOY) France $127.819B 0.00
Medtronic (MDT) Ireland $113.364B 16.07
Lonza Group Ag (LZAGY) Switzerland $50.609B 0.00
Haleon (HLN) United Kingdom $46.066B 26.28
ResMed (RMD) United States $37.677B 28.30
GE HealthCare Technologies (GEHC) United States $34.831B 16.54
Agilent Technologies (A) United States $34.480B 22.48
Terumo (TRUMY) Japan $25.244B 32.79
Koninklijke Philips (PHG) Netherlands $23.274B 16.33
Insulet (PODD) United States $21.186B 83.16
Zimmer Biomet Holdings (ZBH) United States $18.532B 11.90
Baxter (BAX) United States $15.914B 11.88
Smith & Nephew SNATS (SNN) United Kingdom $13.262B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.846B 23.82
Lantheus Holdings (LNTH) United States $5.564B 14.03
Prestige Consumer Healthcare (PBH) United States $3.952B 17.66
Perrigo (PRGO) Ireland $3.739B 9.48
Haemonetics (HAE) United States $3.693B 16.82
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.456B 28.72
ICU Medical (ICUI) United States $3.333B 24.58
QuidelOrtho (QDEL) United States $2.042B 14.04
LeMaitre Vascular (LMAT) United States $1.907B 42.62
AtriCure (ATRC) United States $1.572B 0.00
Acuren (TIC) United States $1.378B 0.00
AdaptHealth (AHCO) United States $1.258B 12.77
Green Thumb Industries (GTBIF) United States $1.164B 26.19
Neogen (NEOG) United States $1.157B 14.81
Phibro Animal Health (PAHC) United States $1.135B 14.51
BioLife Solutions (BLFS) United States $1.085B 0.00
InMode (INMD) Israel $0.958B 9.66
Kestra Medical Technologies (KMTS) United States $0.805B 0.00
Owens & Minor (OMI) United States $0.712B 5.90
CeriBell (CBLL) United States $0.684B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.680B 0.00
Evolus (EOLS) United States $0.598B 0.00
Curaleaf Holdings (CURLF) Canada $0.555B 0.00
Tilray Brands (TLRY) Canada $0.542B 0.00
Valneva SE (VALN) France $0.494B 0.00
Capricor Therapeutics (CAPR) United States $0.468B 0.00
Surmodics (SRDX) United States $0.429B 0.00
VAREX IMAGING (VREX) United States $0.363B 13.33
SEMPERIT AG HLD (SEIGY) Austria $0.360B 0.00
Quanterix (QTRX) United States $0.349B 0.00
SNDL (SNDL) Canada $0.334B 0.00
Cerus (CERS) United States $0.294B 0.00
ZimVie (ZIMV) United States $0.285B 12.98
Viemed Healthcare (VMD) United States $0.283B 23.83
Sanuwave Health (SNWV) United States $0.271B 0.00
Sanara MedTech (SMTI) United States $0.264B 0.00
Aurora Cannabis (ACB) Canada $0.255B 75.67
Brainsway (BWAY) Israel $0.250B 66.20
Cresco Labs (CRLBF) United States $0.246B 0.00
Canopy Growth (CGC) Canada $0.235B 0.00
Biote (BTMD) United States $0.231B 6.49
OraSure Technologies (OSUR) United States $0.230B 0.00
TriSalus Life Sciences (TLSI) United States $0.192B 0.00
Organigram Global (OGI) Canada $0.192B 0.00
Utah Medical Products (UTMD) United States $0.190B 15.46
High Tide (HITI) Canada $0.188B 0.00
Verano Holdings (VRNOF) United States $0.177B 0.00
Exagen (XGN) United States $0.150B 0.00
Vireo Growth (VREOF) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.133B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.097B 12.48
MacroGenics (MGNX) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Veru (VERU) United States $0.089B 0.00
Apyx Medical (APYX) United States $0.087B 0.00
TerrAscend (TSNDF) Canada $0.084B 0.00
Quipt Home Medical (QIPT) United States $0.077B 0.00
Zynex (ZYXI) United States $0.073B 0.00
InterCure (INCR) Israel $0.071B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Agape ATP (ATPC) $0.068B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Nephros (NEPH) United States $0.043B 57.57
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.037B 12.86
Safety Shot (SHOT) United States $0.030B 0.00
Rockwell Medical (RMTI) United States $0.028B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Senestech (SNES) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00